SAT-030 The Barnsley Diabetes Hypogonadal Questionnaire (BDHQ) - Validation for the Clinical Use to Support the Diagnosis of Testosterone Deficiency in Men with Type 2 Diabetes (T2...

por Mumdzic, Enis, Rao, Preethi Mohan, Jones, Thomas Hugh
Publicado 2020

SUN-237 Higher Doses of Testosterone Gel Required in Hypogonadal Men with Obesity to Achieve Therapeutic Replacement - Advice on Dose Titration

por Mumdzic, Enis, Morganti, Emma, Gowda, Siri, Rao, Preethi, Jones, Thomas
Publicado 2019

RF34 | PMON263 Study of Testosterone Replacement in Hypogonadal Men With Uncontrolled Type 2 Diabetes – a Randomised Double Blinded Placebo Controlled Trial (STRIDE Study)

por Mohan Rao, Preethi, Mumdzic, Enis, Kelly, Daniel M, Hugh Jones, T
Publicado 2022

SAT-051 Effects of Testosterone Replacement on Glycemic Control and Other Cardiovascular Risk Factors in Hypogonadal Men with Uncontrolled Type 2 Diabetes (Stride Study): Design, I...

por Rao, Preethi Mohan, Mumdzic, Enis, Kelly, Daniel Marcus, Jones, Thomas Hugh
Publicado 2020

SAT-LB6 First Human Trial of an Oral Native Testosterone Shows Physiological Levels of Testosterone and Dht in Both Fasted and Fed State in Hypogonadal Men

por Newell-Price, John D C, Porter, John, Quirke, Jo, Daniel, Eleni, Mumdzic, Enis, Ross, Richard John M
Publicado 2020

An oral lipidic native testosterone formulation that is absorbed independent of food

por Newell-Price, John, Huatan, Hiep, Quirke, Jo, Porter, John, Daniel, Eleni, Mumdzic, Enis, Voet, Bernard, Keevil, Brian, Whitaker, Martin J, Ross, Richard J
Publicado 2021